New D.C. Law Won’t Affect Medical Meetings

A new law in Washington that requires pharmaceutical sales representatives to obtain a special license to sell pharmaceutical products in the District will not affect representatives attending medical meetings or conventions in D.C.

The SafeRX law, which went into effect April 1, created concern for medical meeting planners who thought that the legislation might have an impact their meetings. Initially,

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish